Menu

Federal Contractor Misconduct Database (FCMD)

The federal government routinely awards contracts to companies with histories of misconduct, including contract fraud and other violations. POGO believes that providing this website will help to improve contracting decisions and increase public knowledge of how the government spends billions of taxpayer dollars each year. Read more…

Paxil New York Litigation

The New York State Attorney General sued GlaxoSmithKline in June 2004, alleging the company withheld negative information about its anti-depression drug Paxil. The suit alleged GSK suppressed the results of studies which failed to prove Paxil’s effectiveness and which suggested a possible increased risk of suicidal thoughts and acts in certain individuals. GSK was further alleged to have failed to disclose this information in medical information letters it sent to physicians. The following August, a settlement was reached in which GSK agreed to pay $2.5 million in disgorgement and costs to the State of New York and to publicly disclose information on all clinical studies — whether positive or negative — of the safety and efficacy of its drugs.

Misconduct Type
Health
Enforcement Agency
State/Local
Contracting Party
None
Court Type
Civil
Disposition
Settlement
Date of Consent Order
8/26/2004
Contractors Involved Penalty
Total
GlaxoSmithKline $2,500,000
Further Information Released
Consent Order 8/24/2007
NYAG Press Release 8/24/2007

Federal Contractor Misconduct Database